Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Complicated Intra-Abdominal Infections Clinical Trial

Official title:
A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Sodium Versus Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults

Status Completed

Clinical Trial Summary

This study is designed to compare the efficacy of ertapenem and piperacillin/tazobactam with respect to the clinical response in baseline microbiologically evaluable patients; and to evaluate the tolerability and safety of ertapenem compared to piperacillin/tazobactam.

Clinical Trial Description

Original label approved November 2001 ;

Study Design

Related Conditions & MeSH terms

Communicable Diseases
Complicated Intra-Abdominal Infections
Infection
Intraabdominal Infections

Clinical Trial Details

NCT number	NCT00389987
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 3
Start date	September 2001
Completion date	May 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02784704` - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections	Phase 3
Completed	`NCT01072539` - Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Completed	`NCT00752219` - Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections	Phase 2
Completed	`NCT03830333` - Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)	Phase 3
Not yet recruiting	`NCT03678298` - Italian Register for the Study of Complicated Intra-Abdominal Infections
Active, not recruiting	`NCT00860587` - Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections	N/A
Completed	`NCT01844856` - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections	Phase 3
Completed	`NCT02475733` - Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).	Phase 2
Completed	`NCT00683332` - Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)	N/A